Tag: covid vaccine

1. Two doses of the CoVLP+AS03 vaccine reduced the risk of contracting coronavirus disease 2019 (COVID-19) and infection severity compared ...

1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection again severe acute respiratory syndrome coronary ...

1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to ...

1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable protection against hospitalization and death. 2. However, ...

1. The AD26.COV2.S vaccine provided protection against moderate to severe-critical Covid-19. 2. The AD26.COV2.S vaccine provided protection against severe Covid-19 ...

1. Two doses of Pfizer-BioNTech vaccine were associated with short-term protection against SARS-CoV-2 infection. 2. Infection-acquired immunity plus vaccination provided ...

1. In a large cohort study, infants whose mothers received the BNT162b2 vaccine during pregnancy were not significantly more likely ...

1. The mRNA Covid-19 vaccine, BNT162b2, has maintained its favorable safety profile through 6 months following vaccination. 2. Despite a ...

1. BNT162b2 mRNA Covid-19 vaccine was efficacious in preventing symptomatic Covid-19 in children 5 to 11 years of age. 2. ...

1. The majority of patients being treated for solid tumour cancers were adequate responders to the vaccine. 2. Serious adverse ...